Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1989 May;42(5):489–494. doi: 10.1136/jcp.42.5.489

Whole blood procoagulant activity in breast and colorectal cancer.

H Mellor 1, I Taylor 1, S Roath 1, J L Francis 1
PMCID: PMC1141954  PMID: 2732342

Abstract

Whole blood procoagulant activity was determined by measuring the recalcification time of citrated blood, with and without the addition of bacterial endotoxin, in patients with breast cancer (n = 39), colorectal cancer (n = 20), benign breast disease (n = 15), benign colorectal disease (n = 11), normal volunteers (n = 15) and inpatients with non-malignant disease (n = 22). The median clotting times of those samples incubated with endotoxin were significantly shorter in the patients with breast and colorectal cancer compared with normal controls. Furthermore, significant differences between the median clotting times of stimulated and unstimulated samples within each subject group were observed only in the two cancer groups. There was no correlation between whole blood procoagulant activity and absolute monocyte counts, with histological staging or with plasma concentrations of plasma fibrinopeptide A. The results suggest that blood from patients with cancer is more sensitive to endotoxin stimulation than that from normal or benign controls, but that in its present form the technique cannot be used to distinguish between malignant and non-malignant disease.

Full text

PDF
490

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auger M. J., Mackie M. J. Monocyte procoagulant activity in breast cancer. Thromb Res. 1987 Jul 1;47(1):77–84. doi: 10.1016/0049-3848(87)90242-8. [DOI] [PubMed] [Google Scholar]
  2. Barrett O., Jr Monocytosis in malignant disease. Ann Intern Med. 1970 Dec;73(6):991–992. doi: 10.7326/0003-4819-73-6-991. [DOI] [PubMed] [Google Scholar]
  3. Calmus Y., Robert A. Increase in monocyte procoagulant activity with age. Thromb Res. 1986 Jan 1;41(1):133–136. doi: 10.1016/0049-3848(86)90286-0. [DOI] [PubMed] [Google Scholar]
  4. Dasmahapatra K. S., Cheung N. K., Spillert C., Lazaro E. An assessment of monocyte procoagulant activity in patients with solid tumors. J Surg Res. 1987 Aug;43(2):158–163. doi: 10.1016/0022-4804(87)90159-4. [DOI] [PubMed] [Google Scholar]
  5. Edwards R. L., Rickles F. R., Cronlund M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med. 1981 Dec;98(6):917–928. [PubMed] [Google Scholar]
  6. Edwards R. L., Rickles F. R. Macrophage procoagulants. Prog Hemost Thromb. 1984;7:183–209. [PubMed] [Google Scholar]
  7. Gordon S. G., Franks J. J., Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res. 1975 Feb;6(2):127–137. doi: 10.1016/0049-3848(75)90018-3. [DOI] [PubMed] [Google Scholar]
  8. Gralnick H. R., Tan H. K. Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis. Hum Pathol. 1974 Nov;5(6):661–673. doi: 10.1016/s0046-8177(74)80037-7. [DOI] [PubMed] [Google Scholar]
  9. Kirk D. Spontaneous regression of metastatic renal carcinoma. Br J Surg. 1987 Jan;74(1):1–2. doi: 10.1002/bjs.1800740102. [DOI] [PubMed] [Google Scholar]
  10. Lorenzet R., Peri G., Locati D., Allavena P., Colucci M., Semeraro N., Mantovani A., Donati M. B. Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood. 1983 Aug;62(2):271–273. [PubMed] [Google Scholar]
  11. Miller C. L., Graziano C., Lim R. C., Chin M. Generation of tissue factor by patient monocytes: correlation to thromboembolic complications. Thromb Haemost. 1981 Aug 28;46(2):489–495. [PubMed] [Google Scholar]
  12. Muller A. D., van Dam-Mieras M. C., Hemker H. C. Measurement of macrophage cellular procoagulant activity. Haemostasis. 1985;15(2):108–113. doi: 10.1159/000215130. [DOI] [PubMed] [Google Scholar]
  13. Mussoni L., Conforti G., Gambacorti-Passerini C., Alessio G., Pepe S., Vaghi M., Erba E., Amato G., Landoni F., Mangioni C. Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture. Eur J Cancer Clin Oncol. 1986 Apr;22(4):373–380. doi: 10.1016/0277-5379(86)90101-x. [DOI] [PubMed] [Google Scholar]
  14. Myers T. J., Rickles F. R., Barb C., Cronlund M. Fibrinopeptide A in acute leukemia: relationship of activation of blood coagulation to disease activity. Blood. 1981 Mar;57(3):518–525. [PubMed] [Google Scholar]
  15. Osterud B., Bjørklid E. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand J Haematol. 1982 Aug;29(2):175–184. doi: 10.1111/j.1600-0609.1982.tb00580.x. [DOI] [PubMed] [Google Scholar]
  16. Peuscher F. W., Cleton F. J., Armstrong L., Stoepman-van Dalen E. A., van Mourik J. A., van Aken W. G. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy. J Lab Clin Med. 1980 Jul;96(1):5–14. [PubMed] [Google Scholar]
  17. Rickles F. R., Edwards R. L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood. 1983 Jul;62(1):14–31. [PubMed] [Google Scholar]
  18. Rickles F. R., Edwards R. L., Barb C., Cronlund M. Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth. Cancer. 1983 Jan 15;51(2):301–307. doi: 10.1002/1097-0142(19830115)51:2<301::aid-cncr2820510223>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  19. Rickles F. R., Levin J., Hardin J. A., Barr C. F., Conrad M. E., Jr Tissue factor generation by human mononuclear cells: effects of endotoxin and dissociation of tissue factor generation from mitogenic response. J Lab Clin Med. 1977 Apr;89(4):792–803. [PubMed] [Google Scholar]
  20. Rivers R. P., Hathaway W. E., Weston W. L. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol. 1975 Jul;30(3):311–316. doi: 10.1111/j.1365-2141.1975.tb00547.x. [DOI] [PubMed] [Google Scholar]
  21. Sakuragawa N., Takahashi K., Hoshiyama M., Jimbo C., Ashizawa K. The extract from the tissue of gastric cancer as procoagulant in disseminated intravascular coagulation syndrome. Thromb Res. 1977 Mar;10(3):457–463. doi: 10.1016/0049-3848(77)90155-4. [DOI] [PubMed] [Google Scholar]
  22. Yoda Y., Abe T. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease. Thromb Haemost. 1981 Dec 23;46(4):706–709. [PubMed] [Google Scholar]
  23. van Ginkel C. J., van Aken W. G., Oh J. I., Vreeken J. Stimulation of monocyte procoagulant activity by adherence to different surfaces. Br J Haematol. 1977 Sep;37(1):35–45. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES